Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

ALAIN HARRIS LITWIN

Allopathic & Osteopathic Physicians Internal Medicine Addiction Medicine

NPI
1366527368
CMS profile
16302
Location
BRONX, NY

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2025 · Entire year

$66,290.83

82 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2025 · entire year · sorted by reported total

By paying entity

PY2025 · entire year · sorted by reported total

Paying entityAmountRecords
Gilead Sciences, Inc. $66,126.54 80
Siemens Medical Solutions USA, Inc. $129.97 1
ABBVIE INC. $34.32 1

Page 2 of 2; records 51–82 of 82 matching records. This page contains 32 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

ALAIN HARRIS LITWIN

NPI 1366527368 · CMS profile ID 16302

Allopathic & Osteopathic Physicians / Internal Medicine / Addiction Medicine

BRONX, NY

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 2 of 2; records 51–82 of 82 matching records. This page contains 32 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1366527368?year=2025&recipient=provider&page=2#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
ALAIN HARRIS LITWIN, NPI 1366527368, CMS profile ID 16302. General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 2; records 51–82 of 82 matching records. This page contains 32 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1366527368?year=2025&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e.
APA 7
IndustryPayments. (2026). ALAIN HARRIS LITWIN, NPI 1366527368, CMS profile ID 16302. General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 2; records 51–82 of 82 matching records. This page contains 32 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1366527368?year=2025&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e.
Bluebook
ALAIN HARRIS LITWIN, NPI 1366527368, CMS profile ID 16302, IndustryPayments, General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 2 of 2; records 51–82 of 82 matching records. This page contains 32 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e. https://industrypayments.org/provider/npi-1366527368?year=2025&recipient=provider&page=2#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2025 · Physicians and non-physician practitioners · CMS publication 2026-06-30

82 matching records · $66,290.83 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 82 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 51–82 of 82.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Gilead Sciences, Inc. $25.0004/04/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1234474414 CMS
Gilead Sciences, Inc. $6.5304/04/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1234596877 CMS
Gilead Sciences, Inc. $3.3004/04/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1234606985 CMS
Gilead Sciences, Inc. $1,076.7604/03/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1234363711 CMS
Gilead Sciences, Inc. $322.8304/03/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1234367940 CMS
Gilead Sciences, Inc. $183.1304/03/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1234370070 CMS
Gilead Sciences, Inc. $79.0004/03/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1234371603 CMS
Gilead Sciences, Inc. $58.2504/03/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1234372269 CMS
Gilead Sciences, Inc. $20.1604/03/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1234374089 CMS
Gilead Sciences, Inc. $8.0004/03/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1234374569 CMS
Gilead Sciences, Inc. $68.8504/03/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1234409503 CMS
Gilead Sciences, Inc. $7.4604/03/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1234593648 CMS
Gilead Sciences, Inc. $3,170.0003/28/2025 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: NEW
06/30/2026 1234355396 CMS
Gilead Sciences, Inc. $113.0503/27/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1234395698 CMS
Gilead Sciences, Inc. $65.9003/20/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1234409705 CMS
Gilead Sciences, Inc. $65.9003/20/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1234409707 CMS
Gilead Sciences, Inc. $23.3403/20/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1234491026 CMS
Gilead Sciences, Inc. $23.3403/20/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1234491028 CMS
Gilead Sciences, Inc. $2.9003/20/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1234607807 CMS
Gilead Sciences, Inc. $2.9003/20/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1234607809 CMS
Gilead Sciences, Inc. $5,990.0003/14/2025 Consulting Fee No dispute reported Delay: No
Change: NEW
06/30/2026 1234350832 CMS
Gilead Sciences, Inc. $5,990.0003/13/2025 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: NEW
06/30/2026 1234353503 CMS
Gilead Sciences, Inc. $5,230.0003/13/2025 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: NEW
06/30/2026 1234353673 CMS
Gilead Sciences, Inc. $1,037.0403/01/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1234363773 CMS
Gilead Sciences, Inc. $284.3903/01/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1234368518 CMS
Gilead Sciences, Inc. $57.6003/01/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1234412352 CMS
Gilead Sciences, Inc. $696.7602/22/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1234364721 CMS
Gilead Sciences, Inc. $60.0102/22/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1234410187 CMS
Gilead Sciences, Inc. $5,970.0002/12/2025 Consulting Fee No dispute reported Delay: No
Change: NEW
06/30/2026 1234350834 CMS
Gilead Sciences, Inc. $2,800.0002/12/2025 Consulting Fee No dispute reported Delay: No
Change: NEW
06/30/2026 1234351512 CMS
Gilead Sciences, Inc. $118.0002/12/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1234371013 CMS
Gilead Sciences, Inc. $84.4002/12/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1234406478 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $13,599.51 7
PY2020 $656.90 1
PY2021 $1,760.00 1
PY2022 $6,592.56 5
PY2023 $4,842.16 7
PY2024 $29,971.73 42
PY2025 $66,290.83 82

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $446,403.81 99
PY2024 Principal investigator $138,424.98 127
PY2023 Principal investigator $429,774.73 55
PY2022 Principal investigator $1,524.35 2
PY2021 Principal investigator $172,120.48 2
PY2020 Principal investigator $456,285.98 3

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

99 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Indivior Inc. $9,834.25 12/16/2025 Covered Recipient Teaching Hospital
PH GREER MEMORIAL HOSPITAL
A PHASE II DOUBLE BLIND, PLACEBO CONTROLLED, RANDOMISED, DOSE-RANGING STUDY TO ASSESS THE SAFETY AND EFFICACY OF INDV-2000 OVER 3 MONTHS IN TREATMENT SEEKING INDIVIDUALS WITH OPIOID USE DISORDER No dispute reported 06/30/2026 1240462754
Principal investigator 1 Indivior Inc. $2,800.00 12/16/2025 Covered Recipient Teaching Hospital
PH GREER MEMORIAL HOSPITAL
A PHASE II DOUBLE BLIND, PLACEBO CONTROLLED, RANDOMISED, DOSE-RANGING STUDY TO ASSESS THE SAFETY AND EFFICACY OF INDV-2000 OVER 3 MONTHS IN TREATMENT SEEKING INDIVIDUALS WITH OPIOID USE DISORDER No dispute reported 06/30/2026 1240462756
Principal investigator 1 Indivior Inc. $150.00 12/16/2025 Covered Recipient Teaching Hospital
PH GREER MEMORIAL HOSPITAL
A PHASE II DOUBLE BLIND, PLACEBO CONTROLLED, RANDOMISED, DOSE-RANGING STUDY TO ASSESS THE SAFETY AND EFFICACY OF INDV-2000 OVER 3 MONTHS IN TREATMENT SEEKING INDIVIDUALS WITH OPIOID USE DISORDER No dispute reported 06/30/2026 1240462758
Principal investigator 1 Indivior Inc. $450.00 12/16/2025 Covered Recipient Teaching Hospital
PH GREER MEMORIAL HOSPITAL
A PHASE II DOUBLE BLIND, PLACEBO CONTROLLED, RANDOMISED, DOSE-RANGING STUDY TO ASSESS THE SAFETY AND EFFICACY OF INDV-2000 OVER 3 MONTHS IN TREATMENT SEEKING INDIVIDUALS WITH OPIOID USE DISORDER No dispute reported 06/30/2026 1240462760
Principal investigator 1 Indivior Inc. $1,500.00 12/16/2025 Covered Recipient Teaching Hospital
PH GREER MEMORIAL HOSPITAL
A PHASE II DOUBLE BLIND, PLACEBO CONTROLLED, RANDOMISED, DOSE-RANGING STUDY TO ASSESS THE SAFETY AND EFFICACY OF INDV-2000 OVER 3 MONTHS IN TREATMENT SEEKING INDIVIDUALS WITH OPIOID USE DISORDER No dispute reported 06/30/2026 1240462762
Principal investigator 1 Indivior Inc. $3,000.00 12/16/2025 Covered Recipient Teaching Hospital
PH GREER MEMORIAL HOSPITAL
A PHASE II DOUBLE BLIND, PLACEBO CONTROLLED, RANDOMISED, DOSE-RANGING STUDY TO ASSESS THE SAFETY AND EFFICACY OF INDV-2000 OVER 3 MONTHS IN TREATMENT SEEKING INDIVIDUALS WITH OPIOID USE DISORDER No dispute reported 06/30/2026 1240462764
Principal investigator 1 Indivior Inc. $190.00 10/02/2025 Covered Recipient Teaching Hospital
PH PATEWOOD HOSPITAL
A PHASE IV LONGITUDINAL STUDY OF SUBLOCADE (SUBUTEX PROLONGED RELEASE) CLINICAL OUTCOMES IN ADULTS WITH OPIOID USE DISORDER (OPIOID DEPENDENCE) No dispute reported 06/30/2026 1240462863
Principal investigator 1 Indivior Inc. $358.00 10/02/2025 Covered Recipient Teaching Hospital
PH PATEWOOD HOSPITAL
A PHASE IV LONGITUDINAL STUDY OF SUBLOCADE (SUBUTEX PROLONGED RELEASE) CLINICAL OUTCOMES IN ADULTS WITH OPIOID USE DISORDER (OPIOID DEPENDENCE) No dispute reported 06/30/2026 1240462865
Principal investigator 1 Indivior Inc. $190.00 10/02/2025 Covered Recipient Teaching Hospital
PH PATEWOOD HOSPITAL
A PHASE IV LONGITUDINAL STUDY OF SUBLOCADE (SUBUTEX PROLONGED RELEASE) CLINICAL OUTCOMES IN ADULTS WITH OPIOID USE DISORDER (OPIOID DEPENDENCE) No dispute reported 06/30/2026 1240462867
Principal investigator 1 Indivior Inc. $6,144.53 09/23/2025 Covered Recipient Teaching Hospital
PH GREER MEMORIAL HOSPITAL
A PHASE II DOUBLE BLIND, PLACEBO CONTROLLED, RANDOMISED, DOSE-RANGING STUDY TO ASSESS THE SAFETY AND EFFICACY OF INDV-2000 OVER 3 MONTHS IN TREATMENT SEEKING INDIVIDUALS WITH OPIOID USE DISORDER No dispute reported 06/30/2026 1240462752
Principal investigator 1 Indivior Inc. $190.00 08/20/2025 Covered Recipient Teaching Hospital
PH PATEWOOD HOSPITAL
A PHASE IV LONGITUDINAL STUDY OF SUBLOCADE (SUBUTEX PROLONGED RELEASE) CLINICAL OUTCOMES IN ADULTS WITH OPIOID USE DISORDER (OPIOID DEPENDENCE) No dispute reported 06/30/2026 1240462854
Principal investigator 1 Indivior Inc. $190.00 08/20/2025 Covered Recipient Teaching Hospital
PH PATEWOOD HOSPITAL
A PHASE IV LONGITUDINAL STUDY OF SUBLOCADE (SUBUTEX PROLONGED RELEASE) CLINICAL OUTCOMES IN ADULTS WITH OPIOID USE DISORDER (OPIOID DEPENDENCE) No dispute reported 06/30/2026 1240462856
Principal investigator 1 Indivior Inc. $358.00 08/20/2025 Covered Recipient Teaching Hospital
PH PATEWOOD HOSPITAL
A PHASE IV LONGITUDINAL STUDY OF SUBLOCADE (SUBUTEX PROLONGED RELEASE) CLINICAL OUTCOMES IN ADULTS WITH OPIOID USE DISORDER (OPIOID DEPENDENCE) No dispute reported 06/30/2026 1240462858
Principal investigator 1 Indivior Inc. $190.00 08/20/2025 Covered Recipient Teaching Hospital
PH PATEWOOD HOSPITAL
A PHASE IV LONGITUDINAL STUDY OF SUBLOCADE (SUBUTEX PROLONGED RELEASE) CLINICAL OUTCOMES IN ADULTS WITH OPIOID USE DISORDER (OPIOID DEPENDENCE) No dispute reported 06/30/2026 1240462861
Principal investigator 1 Indivior Inc. $190.00 07/23/2025 Covered Recipient Teaching Hospital
PH PATEWOOD HOSPITAL
A PHASE IV LONGITUDINAL STUDY OF SUBLOCADE (SUBUTEX PROLONGED RELEASE) CLINICAL OUTCOMES IN ADULTS WITH OPIOID USE DISORDER (OPIOID DEPENDENCE) No dispute reported 06/30/2026 1240462848
Principal investigator 1 Indivior Inc. $190.00 07/23/2025 Covered Recipient Teaching Hospital
PH PATEWOOD HOSPITAL
A PHASE IV LONGITUDINAL STUDY OF SUBLOCADE (SUBUTEX PROLONGED RELEASE) CLINICAL OUTCOMES IN ADULTS WITH OPIOID USE DISORDER (OPIOID DEPENDENCE) No dispute reported 06/30/2026 1240462850
Principal investigator 1 Indivior Inc. $358.00 07/23/2025 Covered Recipient Teaching Hospital
PH PATEWOOD HOSPITAL
A PHASE IV LONGITUDINAL STUDY OF SUBLOCADE (SUBUTEX PROLONGED RELEASE) CLINICAL OUTCOMES IN ADULTS WITH OPIOID USE DISORDER (OPIOID DEPENDENCE) No dispute reported 06/30/2026 1240462852
Principal investigator 1 Indivior Inc. $3,968.39 07/21/2025 Covered Recipient Teaching Hospital
PH GREER MEMORIAL HOSPITAL
A PHASE II DOUBLE BLIND, PLACEBO CONTROLLED, RANDOMISED, DOSE-RANGING STUDY TO ASSESS THE SAFETY AND EFFICACY OF INDV-2000 OVER 3 MONTHS IN TREATMENT SEEKING INDIVIDUALS WITH OPIOID USE DISORDER No dispute reported 06/30/2026 1240462740
Principal investigator 1 Indivior Inc. $2,100.00 07/21/2025 Covered Recipient Teaching Hospital
PH GREER MEMORIAL HOSPITAL
A PHASE II DOUBLE BLIND, PLACEBO CONTROLLED, RANDOMISED, DOSE-RANGING STUDY TO ASSESS THE SAFETY AND EFFICACY OF INDV-2000 OVER 3 MONTHS IN TREATMENT SEEKING INDIVIDUALS WITH OPIOID USE DISORDER No dispute reported 06/30/2026 1240462742
Principal investigator 1 Indivior Inc. $3,107.00 07/21/2025 Covered Recipient Teaching Hospital
PH GREER MEMORIAL HOSPITAL
A PHASE II DOUBLE BLIND, PLACEBO CONTROLLED, RANDOMISED, DOSE-RANGING STUDY TO ASSESS THE SAFETY AND EFFICACY OF INDV-2000 OVER 3 MONTHS IN TREATMENT SEEKING INDIVIDUALS WITH OPIOID USE DISORDER No dispute reported 06/30/2026 1240462744
Principal investigator 1 Indivior Inc. $3,107.00 07/21/2025 Covered Recipient Teaching Hospital
PH GREER MEMORIAL HOSPITAL
A PHASE II DOUBLE BLIND, PLACEBO CONTROLLED, RANDOMISED, DOSE-RANGING STUDY TO ASSESS THE SAFETY AND EFFICACY OF INDV-2000 OVER 3 MONTHS IN TREATMENT SEEKING INDIVIDUALS WITH OPIOID USE DISORDER No dispute reported 06/30/2026 1240462746
Principal investigator 1 Indivior Inc. $950.00 07/21/2025 Covered Recipient Teaching Hospital
PH GREER MEMORIAL HOSPITAL
A PHASE II DOUBLE BLIND, PLACEBO CONTROLLED, RANDOMISED, DOSE-RANGING STUDY TO ASSESS THE SAFETY AND EFFICACY OF INDV-2000 OVER 3 MONTHS IN TREATMENT SEEKING INDIVIDUALS WITH OPIOID USE DISORDER No dispute reported 06/30/2026 1240462748
Principal investigator 1 Indivior Inc. $3,107.00 07/21/2025 Covered Recipient Teaching Hospital
PH GREER MEMORIAL HOSPITAL
A PHASE II DOUBLE BLIND, PLACEBO CONTROLLED, RANDOMISED, DOSE-RANGING STUDY TO ASSESS THE SAFETY AND EFFICACY OF INDV-2000 OVER 3 MONTHS IN TREATMENT SEEKING INDIVIDUALS WITH OPIOID USE DISORDER No dispute reported 06/30/2026 1240462750
Principal investigator 1 Indivior Inc. $129,425.36 06/27/2025 Covered Recipient Teaching Hospital
PH GREER MEMORIAL HOSPITAL
A PHASE II DOUBLE BLIND, PLACEBO CONTROLLED, RANDOMISED, DOSE-RANGING STUDY TO ASSESS THE SAFETY AND EFFICACY OF INDV-2000 OVER 3 MONTHS IN TREATMENT SEEKING INDIVIDUALS WITH OPIOID USE DISORDER No dispute reported 06/30/2026 1240462738
Principal investigator 1 Indivior Inc. $358.00 06/26/2025 Covered Recipient Teaching Hospital
PH PATEWOOD HOSPITAL
A PHASE IV LONGITUDINAL STUDY OF SUBLOCADE (SUBUTEX PROLONGED RELEASE) CLINICAL OUTCOMES IN ADULTS WITH OPIOID USE DISORDER (OPIOID DEPENDENCE) No dispute reported 06/30/2026 1240462834
Principal investigator 1 Indivior Inc. $358.00 06/26/2025 Covered Recipient Teaching Hospital
PH PATEWOOD HOSPITAL
A PHASE IV LONGITUDINAL STUDY OF SUBLOCADE (SUBUTEX PROLONGED RELEASE) CLINICAL OUTCOMES IN ADULTS WITH OPIOID USE DISORDER (OPIOID DEPENDENCE) No dispute reported 06/30/2026 1240462836
Principal investigator 1 Indivior Inc. $190.00 06/26/2025 Covered Recipient Teaching Hospital
PH PATEWOOD HOSPITAL
A PHASE IV LONGITUDINAL STUDY OF SUBLOCADE (SUBUTEX PROLONGED RELEASE) CLINICAL OUTCOMES IN ADULTS WITH OPIOID USE DISORDER (OPIOID DEPENDENCE) No dispute reported 06/30/2026 1240462838
Principal investigator 1 Indivior Inc. $190.00 06/26/2025 Covered Recipient Teaching Hospital
PH PATEWOOD HOSPITAL
A PHASE IV LONGITUDINAL STUDY OF SUBLOCADE (SUBUTEX PROLONGED RELEASE) CLINICAL OUTCOMES IN ADULTS WITH OPIOID USE DISORDER (OPIOID DEPENDENCE) No dispute reported 06/30/2026 1240462840
Principal investigator 1 Indivior Inc. $190.00 06/26/2025 Covered Recipient Teaching Hospital
PH PATEWOOD HOSPITAL
A PHASE IV LONGITUDINAL STUDY OF SUBLOCADE (SUBUTEX PROLONGED RELEASE) CLINICAL OUTCOMES IN ADULTS WITH OPIOID USE DISORDER (OPIOID DEPENDENCE) No dispute reported 06/30/2026 1240462842
Principal investigator 1 Indivior Inc. $190.00 06/26/2025 Covered Recipient Teaching Hospital
PH PATEWOOD HOSPITAL
A PHASE IV LONGITUDINAL STUDY OF SUBLOCADE (SUBUTEX PROLONGED RELEASE) CLINICAL OUTCOMES IN ADULTS WITH OPIOID USE DISORDER (OPIOID DEPENDENCE) No dispute reported 06/30/2026 1240462844
Principal investigator 1 Indivior Inc. $358.00 06/26/2025 Covered Recipient Teaching Hospital
PH PATEWOOD HOSPITAL
A PHASE IV LONGITUDINAL STUDY OF SUBLOCADE (SUBUTEX PROLONGED RELEASE) CLINICAL OUTCOMES IN ADULTS WITH OPIOID USE DISORDER (OPIOID DEPENDENCE) No dispute reported 06/30/2026 1240462846
Principal investigator 1 Indivior Inc. $335.12 06/18/2025 Non-covered Recipient Entity
PRISMA HEALTH ADDICTION
A PHASE II DOUBLE BLIND, PLACEBO CONTROLLED, RANDOMISED, DOSE-RANGING STUDY TO ASSESS THE SAFETY AND EFFICACY OF INDV-2000 OVER 3 MONTHS IN TREATMENT SEEKING INDIVIDUALS WITH OPIOID USE DISORDER No dispute reported 06/30/2026 1240466797
Principal investigator 1 Indivior Inc. $335.12 05/28/2025 Non-covered Recipient Entity
PRISMA HEALTH ADDICTION
A PHASE II DOUBLE BLIND, PLACEBO CONTROLLED, RANDOMISED, DOSE-RANGING STUDY TO ASSESS THE SAFETY AND EFFICACY OF INDV-2000 OVER 3 MONTHS IN TREATMENT SEEKING INDIVIDUALS WITH OPIOID USE DISORDER No dispute reported 06/30/2026 1240466545
Principal investigator 1 Indivior Inc. $190.00 05/23/2025 Covered Recipient Teaching Hospital
PH PATEWOOD HOSPITAL
A PHASE IV LONGITUDINAL STUDY OF SUBLOCADE (SUBUTEX PROLONGED RELEASE) CLINICAL OUTCOMES IN ADULTS WITH OPIOID USE DISORDER (OPIOID DEPENDENCE) No dispute reported 06/30/2026 1240462824
Principal investigator 1 Indivior Inc. $190.00 05/23/2025 Covered Recipient Teaching Hospital
PH PATEWOOD HOSPITAL
A PHASE IV LONGITUDINAL STUDY OF SUBLOCADE (SUBUTEX PROLONGED RELEASE) CLINICAL OUTCOMES IN ADULTS WITH OPIOID USE DISORDER (OPIOID DEPENDENCE) No dispute reported 06/30/2026 1240462826
Principal investigator 1 Indivior Inc. $190.00 05/23/2025 Covered Recipient Teaching Hospital
PH PATEWOOD HOSPITAL
A PHASE IV LONGITUDINAL STUDY OF SUBLOCADE (SUBUTEX PROLONGED RELEASE) CLINICAL OUTCOMES IN ADULTS WITH OPIOID USE DISORDER (OPIOID DEPENDENCE) No dispute reported 06/30/2026 1240462828
Principal investigator 1 Indivior Inc. $358.00 05/23/2025 Covered Recipient Teaching Hospital
PH PATEWOOD HOSPITAL
A PHASE IV LONGITUDINAL STUDY OF SUBLOCADE (SUBUTEX PROLONGED RELEASE) CLINICAL OUTCOMES IN ADULTS WITH OPIOID USE DISORDER (OPIOID DEPENDENCE) No dispute reported 06/30/2026 1240462830
Principal investigator 1 Indivior Inc. $190.00 05/23/2025 Covered Recipient Teaching Hospital
PH PATEWOOD HOSPITAL
A PHASE IV LONGITUDINAL STUDY OF SUBLOCADE (SUBUTEX PROLONGED RELEASE) CLINICAL OUTCOMES IN ADULTS WITH OPIOID USE DISORDER (OPIOID DEPENDENCE) No dispute reported 06/30/2026 1240462832
Principal investigator 1 Indivior Inc. $982.87 05/07/2025 Non-covered Recipient Entity
PRISMA HEALTH ADDICTION
A PHASE II DOUBLE BLIND, PLACEBO CONTROLLED, RANDOMISED, DOSE-RANGING STUDY TO ASSESS THE SAFETY AND EFFICACY OF INDV-2000 OVER 3 MONTHS IN TREATMENT SEEKING INDIVIDUALS WITH OPIOID USE DISORDER No dispute reported 06/30/2026 1240466155
Principal investigator 1 Indivior Inc. $178.94 04/25/2025 Non-covered Recipient Entity
PRISMA HEALTH ADDICTION
A PHASE II DOUBLE BLIND, PLACEBO CONTROLLED, RANDOMISED, DOSE-RANGING STUDY TO ASSESS THE SAFETY AND EFFICACY OF INDV-2000 OVER 3 MONTHS IN TREATMENT SEEKING INDIVIDUALS WITH OPIOID USE DISORDER No dispute reported 06/30/2026 1240466097
Principal investigator 1 Indivior Inc. $358.00 04/23/2025 Covered Recipient Teaching Hospital
PH PATEWOOD HOSPITAL
A PHASE IV LONGITUDINAL STUDY OF SUBLOCADE (SUBUTEX PROLONGED RELEASE) CLINICAL OUTCOMES IN ADULTS WITH OPIOID USE DISORDER (OPIOID DEPENDENCE) No dispute reported 06/30/2026 1240462814
Principal investigator 1 Indivior Inc. $190.00 04/23/2025 Covered Recipient Teaching Hospital
PH PATEWOOD HOSPITAL
A PHASE IV LONGITUDINAL STUDY OF SUBLOCADE (SUBUTEX PROLONGED RELEASE) CLINICAL OUTCOMES IN ADULTS WITH OPIOID USE DISORDER (OPIOID DEPENDENCE) No dispute reported 06/30/2026 1240462816
Principal investigator 1 Indivior Inc. $190.00 04/23/2025 Covered Recipient Teaching Hospital
PH PATEWOOD HOSPITAL
A PHASE IV LONGITUDINAL STUDY OF SUBLOCADE (SUBUTEX PROLONGED RELEASE) CLINICAL OUTCOMES IN ADULTS WITH OPIOID USE DISORDER (OPIOID DEPENDENCE) No dispute reported 06/30/2026 1240462818
Principal investigator 1 Indivior Inc. $358.00 04/23/2025 Covered Recipient Teaching Hospital
PH PATEWOOD HOSPITAL
A PHASE IV LONGITUDINAL STUDY OF SUBLOCADE (SUBUTEX PROLONGED RELEASE) CLINICAL OUTCOMES IN ADULTS WITH OPIOID USE DISORDER (OPIOID DEPENDENCE) No dispute reported 06/30/2026 1240462820
Principal investigator 1 Indivior Inc. $190.00 04/23/2025 Covered Recipient Teaching Hospital
PH PATEWOOD HOSPITAL
A PHASE IV LONGITUDINAL STUDY OF SUBLOCADE (SUBUTEX PROLONGED RELEASE) CLINICAL OUTCOMES IN ADULTS WITH OPIOID USE DISORDER (OPIOID DEPENDENCE) No dispute reported 06/30/2026 1240462822
Principal investigator 1 Indivior Inc. $3,205.51 04/21/2025 Covered Recipient Teaching Hospital
PH GREER MEMORIAL HOSPITAL
A PHASE II DOUBLE BLIND, PLACEBO CONTROLLED, RANDOMISED, DOSE-RANGING STUDY TO ASSESS THE SAFETY AND EFFICACY OF INDV-2000 OVER 3 MONTHS IN TREATMENT SEEKING INDIVIDUALS WITH OPIOID USE DISORDER No dispute reported 06/30/2026 1240462736
Principal investigator 1 Indivior Inc. $476.73 04/10/2025 Non-covered Recipient Entity
PRISMA HEALTH ADDICTION
A PHASE II DOUBLE BLIND, PLACEBO CONTROLLED, RANDOMISED, DOSE-RANGING STUDY TO ASSESS THE SAFETY AND EFFICACY OF INDV-2000 OVER 3 MONTHS IN TREATMENT SEEKING INDIVIDUALS WITH OPIOID USE DISORDER No dispute reported 06/30/2026 1240465681
Principal investigator 1 Indivior Inc. $190.00 04/02/2025 Covered Recipient Teaching Hospital
PH PATEWOOD HOSPITAL
A PHASE IV LONGITUDINAL STUDY OF SUBLOCADE (SUBUTEX PROLONGED RELEASE) CLINICAL OUTCOMES IN ADULTS WITH OPIOID USE DISORDER (OPIOID DEPENDENCE) No dispute reported 06/30/2026 1240462804
Principal investigator 1 Indivior Inc. $190.00 04/02/2025 Covered Recipient Teaching Hospital
PH PATEWOOD HOSPITAL
A PHASE IV LONGITUDINAL STUDY OF SUBLOCADE (SUBUTEX PROLONGED RELEASE) CLINICAL OUTCOMES IN ADULTS WITH OPIOID USE DISORDER (OPIOID DEPENDENCE) No dispute reported 06/30/2026 1240462806
Principal investigator 1 Indivior Inc. $190.00 04/02/2025 Covered Recipient Teaching Hospital
PH PATEWOOD HOSPITAL
A PHASE IV LONGITUDINAL STUDY OF SUBLOCADE (SUBUTEX PROLONGED RELEASE) CLINICAL OUTCOMES IN ADULTS WITH OPIOID USE DISORDER (OPIOID DEPENDENCE) No dispute reported 06/30/2026 1240462808
Principal investigator 1 Indivior Inc. $190.00 04/02/2025 Covered Recipient Teaching Hospital
PH PATEWOOD HOSPITAL
A PHASE IV LONGITUDINAL STUDY OF SUBLOCADE (SUBUTEX PROLONGED RELEASE) CLINICAL OUTCOMES IN ADULTS WITH OPIOID USE DISORDER (OPIOID DEPENDENCE) No dispute reported 06/30/2026 1240462810
Principal investigator 1 Indivior Inc. $190.00 04/02/2025 Covered Recipient Teaching Hospital
PH PATEWOOD HOSPITAL
A PHASE IV LONGITUDINAL STUDY OF SUBLOCADE (SUBUTEX PROLONGED RELEASE) CLINICAL OUTCOMES IN ADULTS WITH OPIOID USE DISORDER (OPIOID DEPENDENCE) No dispute reported 06/30/2026 1240462812
Principal investigator 1 Indivior Inc. $848.92 03/27/2025 Non-covered Recipient Entity
PRISMA HEALTH ADDICTION
A PHASE II DOUBLE BLIND, PLACEBO CONTROLLED, RANDOMISED, DOSE-RANGING STUDY TO ASSESS THE SAFETY AND EFFICACY OF INDV-2000 OVER 3 MONTHS IN TREATMENT SEEKING INDIVIDUALS WITH OPIOID USE DISORDER No dispute reported 06/30/2026 1240465121
Principal investigator 1 Indivior Inc. $133,893.70 03/25/2025 Covered Recipient Teaching Hospital
PH GREER MEMORIAL HOSPITAL
A PHASE II DOUBLE BLIND, PLACEBO CONTROLLED, RANDOMISED, DOSE-RANGING STUDY TO ASSESS THE SAFETY AND EFFICACY OF INDV-2000 OVER 3 MONTHS IN TREATMENT SEEKING INDIVIDUALS WITH OPIOID USE DISORDER No dispute reported 06/30/2026 1240462734
Principal investigator 1 Indivior Inc. $1,146.72 03/12/2025 Non-covered Recipient Entity
PRISMA HEALTH ADDICTION
A PHASE II DOUBLE BLIND, PLACEBO CONTROLLED, RANDOMISED, DOSE-RANGING STUDY TO ASSESS THE SAFETY AND EFFICACY OF INDV-2000 OVER 3 MONTHS IN TREATMENT SEEKING INDIVIDUALS WITH OPIOID USE DISORDER No dispute reported 06/30/2026 1240464914
Principal investigator 1 Indivior Inc. $21,200.00 03/04/2025 Covered Recipient Teaching Hospital
PH GREER MEMORIAL HOSPITAL
A PHASE II DOUBLE BLIND, PLACEBO CONTROLLED, RANDOMISED, DOSE-RANGING STUDY TO ASSESS THE SAFETY AND EFFICACY OF INDV-2000 OVER 3 MONTHS IN TREATMENT SEEKING INDIVIDUALS WITH OPIOID USE DISORDER No dispute reported 06/30/2026 1240462732
Principal investigator 1 Indivior Inc. $190.00 03/03/2025 Covered Recipient Teaching Hospital
PH HILLCREST HOSPITAL
A PHASE IV LONGITUDINAL STUDY OF SUBLOCADE (SUBUTEX PROLONGED RELEASE) CLINICAL OUTCOMES IN ADULTS WITH OPIOID USE DISORDER (OPIOID DEPENDENCE) No dispute reported 06/30/2026 1240462792
Principal investigator 1 Indivior Inc. $358.00 03/03/2025 Covered Recipient Teaching Hospital
PH HILLCREST HOSPITAL
A PHASE IV LONGITUDINAL STUDY OF SUBLOCADE (SUBUTEX PROLONGED RELEASE) CLINICAL OUTCOMES IN ADULTS WITH OPIOID USE DISORDER (OPIOID DEPENDENCE) No dispute reported 06/30/2026 1240462794
Principal investigator 1 Indivior Inc. $190.00 03/03/2025 Covered Recipient Teaching Hospital
PH HILLCREST HOSPITAL
A PHASE IV LONGITUDINAL STUDY OF SUBLOCADE (SUBUTEX PROLONGED RELEASE) CLINICAL OUTCOMES IN ADULTS WITH OPIOID USE DISORDER (OPIOID DEPENDENCE) No dispute reported 06/30/2026 1240462796
Principal investigator 1 Indivior Inc. $190.00 03/03/2025 Covered Recipient Teaching Hospital
PH HILLCREST HOSPITAL
A PHASE IV LONGITUDINAL STUDY OF SUBLOCADE (SUBUTEX PROLONGED RELEASE) CLINICAL OUTCOMES IN ADULTS WITH OPIOID USE DISORDER (OPIOID DEPENDENCE) No dispute reported 06/30/2026 1240462798
Principal investigator 1 Indivior Inc. $190.00 03/03/2025 Covered Recipient Teaching Hospital
PH HILLCREST HOSPITAL
A PHASE IV LONGITUDINAL STUDY OF SUBLOCADE (SUBUTEX PROLONGED RELEASE) CLINICAL OUTCOMES IN ADULTS WITH OPIOID USE DISORDER (OPIOID DEPENDENCE) No dispute reported 06/30/2026 1240462800
Principal investigator 1 Indivior Inc. $1,131.38 03/03/2025 Non-covered Recipient Entity
PRISMA HEALTH ADDICTION
A PHASE II DOUBLE BLIND, PLACEBO CONTROLLED, RANDOMISED, DOSE-RANGING STUDY TO ASSESS THE SAFETY AND EFFICACY OF INDV-2000 OVER 3 MONTHS IN TREATMENT SEEKING INDIVIDUALS WITH OPIOID USE DISORDER No dispute reported 06/30/2026 1240464826
Principal investigator 1 Indivior Inc. $1,458.58 02/21/2025 Non-covered Recipient Entity
PRISMA HEALTH ADDICTION
A PHASE II DOUBLE BLIND, PLACEBO CONTROLLED, RANDOMISED, DOSE-RANGING STUDY TO ASSESS THE SAFETY AND EFFICACY OF INDV-2000 OVER 3 MONTHS IN TREATMENT SEEKING INDIVIDUALS WITH OPIOID USE DISORDER No dispute reported 06/30/2026 1240464382
Principal investigator 1 Indivior Inc. $375.00 02/18/2025 Covered Recipient Teaching Hospital
PH GREER MEMORIAL HOSPITAL
A PHASE II DOUBLE BLIND, PLACEBO CONTROLLED, RANDOMISED, DOSE-RANGING STUDY TO ASSESS THE SAFETY AND EFFICACY OF INDV-2000 OVER 3 MONTHS IN TREATMENT SEEKING INDIVIDUALS WITH OPIOID USE DISORDER No dispute reported 06/30/2026 1240462724
Principal investigator 1 Indivior Inc. $3,107.00 02/18/2025 Covered Recipient Teaching Hospital
PH GREER MEMORIAL HOSPITAL
A PHASE II DOUBLE BLIND, PLACEBO CONTROLLED, RANDOMISED, DOSE-RANGING STUDY TO ASSESS THE SAFETY AND EFFICACY OF INDV-2000 OVER 3 MONTHS IN TREATMENT SEEKING INDIVIDUALS WITH OPIOID USE DISORDER No dispute reported 06/30/2026 1240462726
Principal investigator 1 Indivior Inc. $1,400.00 02/18/2025 Covered Recipient Teaching Hospital
PH GREER MEMORIAL HOSPITAL
A PHASE II DOUBLE BLIND, PLACEBO CONTROLLED, RANDOMISED, DOSE-RANGING STUDY TO ASSESS THE SAFETY AND EFFICACY OF INDV-2000 OVER 3 MONTHS IN TREATMENT SEEKING INDIVIDUALS WITH OPIOID USE DISORDER No dispute reported 06/30/2026 1240462728
Principal investigator 1 Indivior Inc. $1,550.00 02/18/2025 Covered Recipient Teaching Hospital
PH GREER MEMORIAL HOSPITAL
A PHASE II DOUBLE BLIND, PLACEBO CONTROLLED, RANDOMISED, DOSE-RANGING STUDY TO ASSESS THE SAFETY AND EFFICACY OF INDV-2000 OVER 3 MONTHS IN TREATMENT SEEKING INDIVIDUALS WITH OPIOID USE DISORDER No dispute reported 06/30/2026 1240462730
Principal investigator 1 Indivior Inc. $1,918.95 02/12/2025 Non-covered Recipient Entity
PRISMA HEALTH ADDICTION
A PHASE II DOUBLE BLIND, PLACEBO CONTROLLED, RANDOMISED, DOSE-RANGING STUDY TO ASSESS THE SAFETY AND EFFICACY OF INDV-2000 OVER 3 MONTHS IN TREATMENT SEEKING INDIVIDUALS WITH OPIOID USE DISORDER No dispute reported 06/30/2026 1240464246
Principal investigator 1 Indivior Inc. $358.00 01/28/2025 Covered Recipient Teaching Hospital
PH HILLCREST HOSPITAL
A PHASE IV LONGITUDINAL STUDY OF SUBLOCADE (SUBUTEX PROLONGED RELEASE) CLINICAL OUTCOMES IN ADULTS WITH OPIOID USE DISORDER (OPIOID DEPENDENCE) No dispute reported 06/30/2026 1240462766
Principal investigator 1 Indivior Inc. $358.00 01/28/2025 Covered Recipient Teaching Hospital
PH HILLCREST HOSPITAL
A PHASE IV LONGITUDINAL STUDY OF SUBLOCADE (SUBUTEX PROLONGED RELEASE) CLINICAL OUTCOMES IN ADULTS WITH OPIOID USE DISORDER (OPIOID DEPENDENCE) No dispute reported 06/30/2026 1240462768
Principal investigator 1 Indivior Inc. $190.00 01/28/2025 Covered Recipient Teaching Hospital
PH HILLCREST HOSPITAL
A PHASE IV LONGITUDINAL STUDY OF SUBLOCADE (SUBUTEX PROLONGED RELEASE) CLINICAL OUTCOMES IN ADULTS WITH OPIOID USE DISORDER (OPIOID DEPENDENCE) No dispute reported 06/30/2026 1240462770
Principal investigator 1 Indivior Inc. $190.00 01/28/2025 Covered Recipient Teaching Hospital
PH HILLCREST HOSPITAL
A PHASE IV LONGITUDINAL STUDY OF SUBLOCADE (SUBUTEX PROLONGED RELEASE) CLINICAL OUTCOMES IN ADULTS WITH OPIOID USE DISORDER (OPIOID DEPENDENCE) No dispute reported 06/30/2026 1240462772
Principal investigator 1 Indivior Inc. $190.00 01/28/2025 Covered Recipient Teaching Hospital
PH HILLCREST HOSPITAL
A PHASE IV LONGITUDINAL STUDY OF SUBLOCADE (SUBUTEX PROLONGED RELEASE) CLINICAL OUTCOMES IN ADULTS WITH OPIOID USE DISORDER (OPIOID DEPENDENCE) No dispute reported 06/30/2026 1240462774
Principal investigator 1 Indivior Inc. $358.00 01/28/2025 Covered Recipient Teaching Hospital
PH HILLCREST HOSPITAL
A PHASE IV LONGITUDINAL STUDY OF SUBLOCADE (SUBUTEX PROLONGED RELEASE) CLINICAL OUTCOMES IN ADULTS WITH OPIOID USE DISORDER (OPIOID DEPENDENCE) No dispute reported 06/30/2026 1240462776
Principal investigator 1 Indivior Inc. $358.00 01/28/2025 Covered Recipient Teaching Hospital
PH HILLCREST HOSPITAL
A PHASE IV LONGITUDINAL STUDY OF SUBLOCADE (SUBUTEX PROLONGED RELEASE) CLINICAL OUTCOMES IN ADULTS WITH OPIOID USE DISORDER (OPIOID DEPENDENCE) No dispute reported 06/30/2026 1240462778
Principal investigator 1 Indivior Inc. $190.00 01/28/2025 Covered Recipient Teaching Hospital
PH HILLCREST HOSPITAL
A PHASE IV LONGITUDINAL STUDY OF SUBLOCADE (SUBUTEX PROLONGED RELEASE) CLINICAL OUTCOMES IN ADULTS WITH OPIOID USE DISORDER (OPIOID DEPENDENCE) No dispute reported 06/30/2026 1240462780
Principal investigator 1 Indivior Inc. $190.00 01/28/2025 Covered Recipient Teaching Hospital
PH HILLCREST HOSPITAL
A PHASE IV LONGITUDINAL STUDY OF SUBLOCADE (SUBUTEX PROLONGED RELEASE) CLINICAL OUTCOMES IN ADULTS WITH OPIOID USE DISORDER (OPIOID DEPENDENCE) No dispute reported 06/30/2026 1240462782
Principal investigator 1 Indivior Inc. $190.00 01/28/2025 Covered Recipient Teaching Hospital
PH HILLCREST HOSPITAL
A PHASE IV LONGITUDINAL STUDY OF SUBLOCADE (SUBUTEX PROLONGED RELEASE) CLINICAL OUTCOMES IN ADULTS WITH OPIOID USE DISORDER (OPIOID DEPENDENCE) No dispute reported 06/30/2026 1240462784
Principal investigator 1 Indivior Inc. $190.00 01/28/2025 Covered Recipient Teaching Hospital
PH HILLCREST HOSPITAL
A PHASE IV LONGITUDINAL STUDY OF SUBLOCADE (SUBUTEX PROLONGED RELEASE) CLINICAL OUTCOMES IN ADULTS WITH OPIOID USE DISORDER (OPIOID DEPENDENCE) No dispute reported 06/30/2026 1240462786
Principal investigator 1 Indivior Inc. $358.00 01/28/2025 Covered Recipient Teaching Hospital
PH HILLCREST HOSPITAL
A PHASE IV LONGITUDINAL STUDY OF SUBLOCADE (SUBUTEX PROLONGED RELEASE) CLINICAL OUTCOMES IN ADULTS WITH OPIOID USE DISORDER (OPIOID DEPENDENCE) No dispute reported 06/30/2026 1240462788
Principal investigator 1 Indivior Inc. $190.00 01/28/2025 Covered Recipient Teaching Hospital
PH HILLCREST HOSPITAL
A PHASE IV LONGITUDINAL STUDY OF SUBLOCADE (SUBUTEX PROLONGED RELEASE) CLINICAL OUTCOMES IN ADULTS WITH OPIOID USE DISORDER (OPIOID DEPENDENCE) No dispute reported 06/30/2026 1240462790
Principal investigator 1 Indivior Inc. $893.40 01/24/2025 Non-covered Recipient Entity
PRISMA HEALTH ADDICTION
A PHASE II DOUBLE BLIND, PLACEBO CONTROLLED, RANDOMISED, DOSE-RANGING STUDY TO ASSESS THE SAFETY AND EFFICACY OF INDV-2000 OVER 3 MONTHS IN TREATMENT SEEKING INDIVIDUALS WITH OPIOID USE DISORDER No dispute reported 06/30/2026 1240463451
Principal investigator 1 Indivior Inc. $34,545.28 01/08/2025 Covered Recipient Teaching Hospital
PH GREER MEMORIAL HOSPITAL
A PHASE II DOUBLE BLIND, PLACEBO CONTROLLED, RANDOMISED, DOSE-RANGING STUDY TO ASSESS THE SAFETY AND EFFICACY OF INDV-2000 OVER 3 MONTHS IN TREATMENT SEEKING INDIVIDUALS WITH OPIOID USE DISORDER No dispute reported 06/30/2026 1240462722
Principal investigator 1 Indivior Inc. $3,121.65 01/08/2025 Non-covered Recipient Entity
PRISMA HEALTH ADDICTION
A PHASE II DOUBLE BLIND, PLACEBO CONTROLLED, RANDOMISED, DOSE-RANGING STUDY TO ASSESS THE SAFETY AND EFFICACY OF INDV-2000 OVER 3 MONTHS IN TREATMENT SEEKING INDIVIDUALS WITH OPIOID USE DISORDER No dispute reported 06/30/2026 1240463061
Principal investigator 1 Indivior Inc. $25,649.00 01/07/2025 Covered Recipient Teaching Hospital
PH PATEWOOD HOSPITAL
A RANDOMISED, DOUBLE-BLIND STUDY COMPARING 2 MAINTENANCE DOSING REGIMENS OF BUPRENORPHINE EXTENDED-RELEASE SUBCUTANEOUS INJECTION (RBP-6000) IN TREATMENT-SEEKING ADULT PARTICIPANTS WITH OPIOID USE DISORDER AND HIGH-RISK OPIOID USE No dispute reported 06/30/2026 1240462802
Principal investigator 1 Indivior Inc. $1,337.41 01/07/2025 Non-covered Recipient Entity
PRISMA HEALTH ADDICTION
A PHASE II DOUBLE BLIND, PLACEBO CONTROLLED, RANDOMISED, DOSE-RANGING STUDY TO ASSESS THE SAFETY AND EFFICACY OF INDV-2000 OVER 3 MONTHS IN TREATMENT SEEKING INDIVIDUALS WITH OPIOID USE DISORDER No dispute reported 06/30/2026 1240463055
Principal investigator 1 Indivior Inc. $1,973.00 01/03/2025 Covered Recipient Teaching Hospital
GHS GREENVILLE MEMORIAL HOSPITAL
A RANDOMISED, DOUBLE-BLIND STUDY COMPARING 2 MAINTENANCE DOSING REGIMENS OF BUPRENORPHINE EXTENDED-RELEASE SUBCUTANEOUS INJECTION (RBP-6000) IN TREATMENT-SEEKING ADULT PARTICIPANTS WITH OPIOID USE DISORDER AND HIGH-RISK OPIOID USE No dispute reported 06/30/2026 1240462300
Principal investigator 1 Indivior Inc. $1,973.00 01/03/2025 Covered Recipient Teaching Hospital
GHS GREENVILLE MEMORIAL HOSPITAL
A RANDOMISED, DOUBLE-BLIND STUDY COMPARING 2 MAINTENANCE DOSING REGIMENS OF BUPRENORPHINE EXTENDED-RELEASE SUBCUTANEOUS INJECTION (RBP-6000) IN TREATMENT-SEEKING ADULT PARTICIPANTS WITH OPIOID USE DISORDER AND HIGH-RISK OPIOID USE No dispute reported 06/30/2026 1240462302
Principal investigator 1 Indivior Inc. $1,973.00 01/03/2025 Covered Recipient Teaching Hospital
GHS GREENVILLE MEMORIAL HOSPITAL
A RANDOMISED, DOUBLE-BLIND STUDY COMPARING 2 MAINTENANCE DOSING REGIMENS OF BUPRENORPHINE EXTENDED-RELEASE SUBCUTANEOUS INJECTION (RBP-6000) IN TREATMENT-SEEKING ADULT PARTICIPANTS WITH OPIOID USE DISORDER AND HIGH-RISK OPIOID USE No dispute reported 06/30/2026 1240462304
Principal investigator 1 Indivior Inc. $1,973.00 01/03/2025 Covered Recipient Teaching Hospital
GHS GREENVILLE MEMORIAL HOSPITAL
A RANDOMISED, DOUBLE-BLIND STUDY COMPARING 2 MAINTENANCE DOSING REGIMENS OF BUPRENORPHINE EXTENDED-RELEASE SUBCUTANEOUS INJECTION (RBP-6000) IN TREATMENT-SEEKING ADULT PARTICIPANTS WITH OPIOID USE DISORDER AND HIGH-RISK OPIOID USE No dispute reported 06/30/2026 1240462306
Principal investigator 1 Indivior Inc. $1,973.00 01/03/2025 Covered Recipient Teaching Hospital
GHS GREENVILLE MEMORIAL HOSPITAL
A RANDOMISED, DOUBLE-BLIND STUDY COMPARING 2 MAINTENANCE DOSING REGIMENS OF BUPRENORPHINE EXTENDED-RELEASE SUBCUTANEOUS INJECTION (RBP-6000) IN TREATMENT-SEEKING ADULT PARTICIPANTS WITH OPIOID USE DISORDER AND HIGH-RISK OPIOID USE No dispute reported 06/30/2026 1240462308
Principal investigator 1 Indivior Inc. $1,973.00 01/03/2025 Covered Recipient Teaching Hospital
GHS GREENVILLE MEMORIAL HOSPITAL
A RANDOMISED, DOUBLE-BLIND STUDY COMPARING 2 MAINTENANCE DOSING REGIMENS OF BUPRENORPHINE EXTENDED-RELEASE SUBCUTANEOUS INJECTION (RBP-6000) IN TREATMENT-SEEKING ADULT PARTICIPANTS WITH OPIOID USE DISORDER AND HIGH-RISK OPIOID USE No dispute reported 06/30/2026 1240462310
Principal investigator 1 Indivior Inc. $1,973.00 01/03/2025 Covered Recipient Teaching Hospital
GHS GREENVILLE MEMORIAL HOSPITAL
A RANDOMISED, DOUBLE-BLIND STUDY COMPARING 2 MAINTENANCE DOSING REGIMENS OF BUPRENORPHINE EXTENDED-RELEASE SUBCUTANEOUS INJECTION (RBP-6000) IN TREATMENT-SEEKING ADULT PARTICIPANTS WITH OPIOID USE DISORDER AND HIGH-RISK OPIOID USE No dispute reported 06/30/2026 1240462312
Principal investigator 1 Indivior Inc. $1,973.00 01/03/2025 Covered Recipient Teaching Hospital
GHS GREENVILLE MEMORIAL HOSPITAL
A RANDOMISED, DOUBLE-BLIND STUDY COMPARING 2 MAINTENANCE DOSING REGIMENS OF BUPRENORPHINE EXTENDED-RELEASE SUBCUTANEOUS INJECTION (RBP-6000) IN TREATMENT-SEEKING ADULT PARTICIPANTS WITH OPIOID USE DISORDER AND HIGH-RISK OPIOID USE No dispute reported 06/30/2026 1240462314
Principal investigator 1 Indivior Inc. $1,973.00 01/03/2025 Covered Recipient Teaching Hospital
GHS GREENVILLE MEMORIAL HOSPITAL
A RANDOMISED, DOUBLE-BLIND STUDY COMPARING 2 MAINTENANCE DOSING REGIMENS OF BUPRENORPHINE EXTENDED-RELEASE SUBCUTANEOUS INJECTION (RBP-6000) IN TREATMENT-SEEKING ADULT PARTICIPANTS WITH OPIOID USE DISORDER AND HIGH-RISK OPIOID USE No dispute reported 06/30/2026 1240462316
Principal investigator 1 Indivior Inc. $1,973.00 01/03/2025 Covered Recipient Teaching Hospital
GHS GREENVILLE MEMORIAL HOSPITAL
A RANDOMISED, DOUBLE-BLIND STUDY COMPARING 2 MAINTENANCE DOSING REGIMENS OF BUPRENORPHINE EXTENDED-RELEASE SUBCUTANEOUS INJECTION (RBP-6000) IN TREATMENT-SEEKING ADULT PARTICIPANTS WITH OPIOID USE DISORDER AND HIGH-RISK OPIOID USE No dispute reported 06/30/2026 1240462318
Principal investigator 1 Indivior Inc. $1,973.00 01/03/2025 Covered Recipient Teaching Hospital
GHS GREENVILLE MEMORIAL HOSPITAL
A RANDOMISED, DOUBLE-BLIND STUDY COMPARING 2 MAINTENANCE DOSING REGIMENS OF BUPRENORPHINE EXTENDED-RELEASE SUBCUTANEOUS INJECTION (RBP-6000) IN TREATMENT-SEEKING ADULT PARTICIPANTS WITH OPIOID USE DISORDER AND HIGH-RISK OPIOID USE No dispute reported 06/30/2026 1240462320
Principal investigator 1 Indivior Inc. $1,973.00 01/03/2025 Covered Recipient Teaching Hospital
GHS GREENVILLE MEMORIAL HOSPITAL
A RANDOMISED, DOUBLE-BLIND STUDY COMPARING 2 MAINTENANCE DOSING REGIMENS OF BUPRENORPHINE EXTENDED-RELEASE SUBCUTANEOUS INJECTION (RBP-6000) IN TREATMENT-SEEKING ADULT PARTICIPANTS WITH OPIOID USE DISORDER AND HIGH-RISK OPIOID USE No dispute reported 06/30/2026 1240462322
Principal investigator 1 Indivior Inc. $1,973.00 01/03/2025 Covered Recipient Teaching Hospital
GHS GREENVILLE MEMORIAL HOSPITAL
A RANDOMISED, DOUBLE-BLIND STUDY COMPARING 2 MAINTENANCE DOSING REGIMENS OF BUPRENORPHINE EXTENDED-RELEASE SUBCUTANEOUS INJECTION (RBP-6000) IN TREATMENT-SEEKING ADULT PARTICIPANTS WITH OPIOID USE DISORDER AND HIGH-RISK OPIOID USE No dispute reported 06/30/2026 1240462324